Week of January 24th 2022 | Vol. 11, Issue 4
In This Issue
Upcoming Events
Industry M&A Activity
Recent Transactions
Trading Comps
Market Reports
M&A Pipeline
Featured Headlines
Tanner Updates

Quick Links

Contact Information
Managing Director
Business Development

Managing Director
Head of M&A and Capital Advisory
Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to download complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners
March 21-24, 2022 - New York City, NY

October 2022- Charlotte, NC
INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
M&A TRANSACTIONS
Pharma & Biotech
7 transactions totaling $1,958 million

Supplies, Equipment & Services
26 transactions totaling $185 million

Healthcare IT & Managed Care
10 transactions totaling $14

Healthcare Facilities & Distributors
7 transactions totaling $49 million
PRIVATE PLACEMENTS
Pharma & Biotech
32 transactions totaling $664 million

Supplies, Equipment & Services
26 transactions totaling $315 million

Healthcare IT & Managed Care
15 transactions totaling $447 million

Healthcare Facilities & Distributors
2 transactions
PUBLIC OFFERINGS
Pharma & Biotech
7 transactions totaling $410 million

Supplies, Equipment & Services
4 transactions totaling $12 million

Healthcare IT & Managed Care
1 transaction

Healthcare Facilities & Distributors
0 transactions
TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
MARKET REPORTS
Insight Into Healthcare Related Industries
M&A PIPELINE
Representative Current Retained Sell-Side And Partnering Opportunities
Project Alamo
Sell-side | CMO | Corporate Carve out - private label and OTC manufacturing business

Project Focus
Sell-side | CMO | Liquids and Semi-solids CMO headquartered in North America

Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
FEATURED HEADLINES
A Sampling of Industry Headlines From Last Week
Women are the "power buyers" of healthcare, controlling about 80% of the healthcare spend in the U.S., which is a nearly $4 trillion industry.

Women's health is now in the spotlight, and investors have been quick to put their cash into this growing market.

Digital health startups focused on women's health care pulled in $1.3 billion in funding across 26 deals by October 2021—nearly doubling all of 2020's funding with four months still left to go, according to digital health venture fund Rock Health.
Kidney care giant DaVita has acquired transplant software company MedSleuth to ease access burdens on kidney and liver transplant candidates.
The pharmaceutical industry picked up digital clinical trial tools during the pandemic that can also be used to tackle the lack of diversity in research. So that’s it. The issue is solved.
With healthcare increasingly placing bets on artificial intelligence, Microsoft has formed a coalition with some of the nation’s top health and life sciences organizations to build and track new AI innovations.
High bed counts, few primary care physicians and investor ownership are common themes among health systems frequently delivering low- or no-value medical services, according to a recent analysis.

The Medicine Maker features Banks Bourne, Founder and CEO of Tanner Pharma Group, as he discusses how companies can reimagine and strengthen their supply chains when presented with unique challenges.

Check out Tanner’s feature in the 2022 CTS Handbook highlighting the company’s capabilities in solving the most complex sourcing and supply challenges.